Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, B-Cell × liposomal doxorubicin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 47 Ovarian Neoplasms 35 Multiple Myeloma 17 Sarcoma 11 Carcinoma, Ovarian Epithelial 11 Lymphoma 10 Fallopian Tube Neoplasms 10 Triple Negative Breast Neoplasms 9 Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Recurrence 5 Prostatic Neoplasms 5 Neoplasms, Plasma Cell 5 Sarcoma, Ewing 4 Neoplasm Metastasis 4 Burkitt Lymphoma 4 Rhabdomyosarcoma 3 Pancreatic Neoplasms 3 Osteosarcoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Mantle-Cell 3 Breast Neoplasms, Male 3 Uterine Cervical Neoplasms 2 Solid Tumors 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Follicular 2

Interventions

Cyclophosphamide 59 Rituximab 52 fludarabine 38 Etoposide 19 Lenalidomide 18 fludarabine phosphate 16 Doxorubicin 14 Vincristine 12 Magnetic Resonance Spectroscopy 12 Immunotherapy, Adoptive 12 Cytarabine 12 Prednisone 11 pembrolizumab 10 Specimen Handling 9 CT-P10 9 Biopsy 8 obinutuzumab 7 ibrutinib 7 Radiotherapy 7 Carboplatin 7 Bortezomib 7 Bendamustine Hydrochloride 7 Mycophenolic Acid 6 Leukapheresis 6 Ifosfamide 6 zanubrutinib 5 Nivolumab 5 Melphalan 5 Injections 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡